Dr Andrew Oar is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC), Gold Coast. He completed his postgraduate medical training at the University of Queensland in 2010. Immediately following his medical training, he completed a Masters of International Public Health (MIPH) in 2011. He completed the majority of his specialist training at Liverpool and Campbelltown Hospitals in Sydney. He underwent a fellowship in lung and gastrointestinal cancer as well as stereotactic radiation therapy. Dr Oar completed his specialist radiation oncology examinations in August 2016, and became an eligible Fellow of the Royal Australian and New Zealand College of Radiologists (RANZCR) in May 2018.
Dr Oar has presented his research work into pancreatic cancer and magnetic resonance imaging (MRI) at both national and international conferences. He is an executive member of the Asia Pacific Radiation Oncology Special Interest Group (APROSIG). He is a conjoint lecturer at the University of New South Wales (UNSW) and University of Western Sydney (UWS).
He is currently the clinical Research lead at ROC Gold Coast and is actively involved in several clinical trials. He is the principal investigator of the MASTERPLAN trial, a national randomised trial investigating stereotactic radiotherapy in pancreas cancer, which will begin recruitment in 2019. His areas of interest include gastrointestinal, skin, lung, genitourinary, central nervous system (CNS) cancers as well as stereotactic radiation therapy.